Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma.

Purohit, A

Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma. [electronic resource] - Lung cancer (Amsterdam, Netherlands) Nov 1998 - 119-25 p. digital

Publication Type: Clinical Trial; Journal Article

0169-5002

10.1016/s0169-5002(98)00072-5 doi


Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cisplatin--administration & dosage
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Interferon alpha-2
Interferon-alpha--administration & dosage
Male
Mesothelioma--drug therapy
Middle Aged
Pleural Neoplasms--drug therapy
Recombinant Proteins